Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment Decentralization
Sponsor: Hoffmann-La Roche
Summary
The main purpose of this study is to evaluate the impact of a decentralized treatment model on treatment adherence in participants with early-stage human epidermal growth factor receptor 2- positive (HER2+) breast cancer (BC). This study has 2 groups: Group 1: Consistent Travel Burden (Cohorts A, C, and D), will include participants whose adjuvant therapy location does not increase their travel requirements, and Group 2: Increased Travel Burden (Cohort B), will include participants who must travel from a secondary center to a tertiary center to receive their adjuvant therapy.
Official title: Real-World Research of Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer in Serbia After Treatment Decentralization (Close2HER)
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-02-23
Completion Date
2028-05-31
Last Updated
2026-05-08
Healthy Volunteers
No
Conditions
Locations (10)
Health Centre Loznica
Loznica, Bolnička 65, Serbia
General Hospital Požarevac
Požarevac, Bratstva Jedinstva 135, Serbia
Healthcare Centre Bor
Bor, Dragiše Mišovića 1, Serbia
Health Centre Kladovo
Kladovo, Dunavska 1-3, Serbia
Health Centre ''Sveti Luka'' Smederevo
Smederevo, Knez Mihailova 51, Serbia
General Hospital Pančevo
Pančevo, Miloša Trebinjca 11, Serbia
Institute for Onocology and Radiology of Serbia
Belgrade, Pasterova 14, Serbia
General Hospital "Dr Laza K. Lazarevic" Sabac
Šabac, Popa Karana 2-4, Serbia
Health Centre Valjevo
Valjevo, Sinđelićeva 62, Serbia
General Hospital ''Stefan Visoki'' Smederevska Palanka
Smederevska Palanka, Vuka Karadžića 147, Serbia